This inventor holds 8 USPTO granted patents and 8 published patent applications and 3 EPO patents. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2012-2025.
Location History:
- Washington, DC (US) (2012 - 2021)
- Chevy Chase, MD (US) (2022)
Company Filing History:
Years Active: 2012-2025
Title: Randy J Chandler: Innovator in Viral Gene Therapy
Introduction
Randy J Chandler is a prominent inventor based in Washington, DC, known for his significant contributions to the field of viral gene therapy. With a total of 8 patents, Chandler has focused on developing innovative treatments for cholesterol storage diseases, particularly Niemann-Pick disease, Type C.
Latest Patents
Chandler's latest patents include groundbreaking work on viral gene therapy as a treatment for cholesterol storage disorders. One of his notable inventions involves compositions and methods for AAV-directed gene therapy aimed at addressing Niemann-Pick disease, Type C. Additionally, he has developed codon-optimized human NPC1 genes for the treatment of Niemann-Pick type C1 deficiency and related conditions, further advancing the potential for effective therapies in this area.
Career Highlights
Chandler works for the United States of America, as Represented by the Secretary, Department of Health and Human Services. His career is marked by a commitment to improving health outcomes through innovative research and development in gene therapy.
Collaborations
Chandler has collaborated with esteemed colleagues in his field, including Charles P Venditti and William J Pavan. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Randy J Chandler's work in viral gene therapy represents a significant advancement in the treatment of cholesterol storage diseases. His innovative patents and collaborations highlight his dedication to improving patient care through scientific research.